<it>IL6 and CRP </it>haplotypes are associated with COPD risk and systemic inflammation: a case-control study
<p>Abstract</p> <p>Background</p> <p>Elevated circulating levels of C-reactive protein (CRP), interleukin (IL)-6 and fibrinogen (FG) have been repeatedly associated with many adverse outcomes in patients with chronic obstructive pulmonary disease (COPD). To date, it rem...
Main Authors: | Passos Valéria, Kotz Daniel, Houwing-Duistermaat Jeanine J, Spruit Martijn A, Dentener Mieke A, Yanbaeva Dilyara G, Wouters Emiel FM |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-03-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/10/23 |
Similar Items
-
End-of-life care in a COPD patient awaiting lung transplantation: a case report
by: Schols Jos MGA, et al.
Published: (2010-04-01) -
COPD and exercise: does it make a difference?
by: Martijn A. Spruit, et al.
Published: (2016-06-01) -
Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons
by: Munuswamy R, et al.
Published: (2021-09-01) -
Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study
by: Wilke Sarah, et al.
Published: (2012-08-01) -
The superexacerbator phenotype in patients with COPD: a descriptive analysis
by: Lowie E.G.W. Vanfleteren, et al.
Published: (2019-06-01)